# Iron Metabolism and Disorders
**Type:** Topics
**Canonical URL:** https://scholariq.org/topics/iron-metabolism-and-disorders/
## Facts
| Field | Value |
| --- | --- |
| Description | This cluster of papers focuses on the regulation of iron metabolism, including the role of hepcidin, ferroportin, and transferrin in maintaining iron homeostasis. It also explores the impact of inflammation, anemia, and oxidative stress on iron levels, as well as the association between iron deficiency and conditions such as hemochromatosis. |
| Domain | Health Sciences |
| Field | Medicine |
| OpenAlex ID | t10452 |
| Works | 457 |
## Topic papers all
Showing 15 of 457.
- [Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients](https://scholariq.org/papers/targeting-hypoxia-inducible-factors-for-the-treatment-of-anemia-in-chronic/)
- [Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia](https://scholariq.org/papers/normalization-of-hemoglobin-level-in-patients-with-chronic-kidney-disease-and/)
- [Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency](https://scholariq.org/papers/ferric-carboxymaltose-in-patients-with-heart-failure-and-iron-deficiency/)
- [A Novel Duodenal Iron-Regulated Transporter, IREG1, Implicated in the Basolateral Transfer of Iron to the Circulation](https://scholariq.org/papers/a-novel-duodenal-iron-regulated-transporter-ireg1-implicated-in-the-basolateral/)
- [Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency](https://scholariq.org/papers/beneficial-effects-of-long-term-intravenous-iron-therapy-with-ferric/)
- [The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia](https://scholariq.org/papers/the-elephant-in-uremia-oxidant-stress-as-a-unifying-concept-of-cardiovascular/)
- [Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine.](https://scholariq.org/papers/survival-and-complications-in-patients-with-thalassemia-major-treated-with/)
- [Iron-Chelating Therapy and the Treatment of Thalassemia](https://scholariq.org/papers/iron-chelating-therapy-and-the-treatment-of-thalassemia/)
- [Ferritin: a cytoprotective antioxidant strategem of endothelium.](https://scholariq.org/papers/ferritin-a-cytoprotective-antioxidant-strategem-of-endothelium/)
- [An Iron-Regulated Ferric Reductase Associated with the Absorption of Dietary Iron](https://scholariq.org/papers/an-iron-regulated-ferric-reductase-associated-with-the-absorption-of-dietary/)
- [Essential metals in health and disease](https://scholariq.org/papers/essential-metals-in-health-and-disease/)
- [Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences](https://scholariq.org/papers/malnutrition-inflammation-complex-syndrome-in-dialysis-patients-causes-and/)
- [Nutritional Assessment](https://scholariq.org/papers/nutritional-assessment/)
- [Diagnosis and phenotypic classification of Wilson disease1](https://scholariq.org/papers/diagnosis-and-phenotypic-classification-of-wilson-disease-sup-1-sup/)
- [Nutritional aspects of manganese homeostasis](https://scholariq.org/papers/nutritional-aspects-of-manganese-homeostasis/)
## Topic primary papers
Showing 15 of 173.
- [A Novel Duodenal Iron-Regulated Transporter, IREG1, Implicated in the Basolateral Transfer of Iron to the Circulation](https://scholariq.org/papers/a-novel-duodenal-iron-regulated-transporter-ireg1-implicated-in-the-basolateral/)
- [An Iron-Regulated Ferric Reductase Associated with the Absorption of Dietary Iron](https://scholariq.org/papers/an-iron-regulated-ferric-reductase-associated-with-the-absorption-of-dietary/)
- [Nanoparticle Size Is a Critical Physicochemical Determinant of the Human Blood Plasma Corona: A Comprehensive Quantitative Proteomic Analysis](https://scholariq.org/papers/nanoparticle-size-is-a-critical-physicochemical-determinant-of-the-human-blood/)
- [Hemochromatosis and Iron-Overload Screening in a Racially Diverse Population](https://scholariq.org/papers/hemochromatosis-and-iron-overload-screening-in-a-racially-diverse-population/)
- [Iron-Overload–Related Disease inHFEHereditary Hemochromatosis](https://scholariq.org/papers/iron-overload-related-disease-in-i-hfe-i-hereditary-hemochromatosis/)
- [A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression](https://scholariq.org/papers/a-role-of-smad4-in-iron-metabolism-through-the-positive-regulation-of-hepcidin/)
- [Hepatic transferrin plays a role in systemic iron homeostasis and liver ferroptosis](https://scholariq.org/papers/hepatic-transferrin-plays-a-role-in-systemic-iron-homeostasis-and-liver/)
- [Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study 2021](https://scholariq.org/papers/prevalence-years-lived-with-disability-and-trends-in-anaemia-burden-by-severity/)
- [Laboratory diagnosis of iron-deficiency anemia](https://scholariq.org/papers/laboratory-diagnosis-of-iron-deficiency-anemia/)
- [Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women](https://scholariq.org/papers/oral-iron-supplements-increase-hepcidin-and-decrease-iron-absorption-from-daily/)
- [HFE gene knockout produces mouse model of hereditary hemochromatosis](https://scholariq.org/papers/hfe-gene-knockout-produces-mouse-model-of-hereditary-hemochromatosis/)
- [Prevalence of anaemia in older persons: systematic review](https://scholariq.org/papers/prevalence-of-anaemia-in-older-persons-systematic-review/)
- [Intravenous Iron in Patients Undergoing Maintenance Hemodialysis](https://scholariq.org/papers/intravenous-iron-in-patients-undergoing-maintenance-hemodialysis/)
- [The Hemochromatosis Founder Mutation in HLA-H Disrupts β2-Microglobulin Interaction and Cell Surface Expression](https://scholariq.org/papers/the-hemochromatosis-founder-mutation-in-hla-h-disrupts-2-microglobulin/)
- [Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference](https://scholariq.org/papers/iron-management-in-chronic-kidney-disease-conclusions-from-a-kidney-disease/)
---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.